ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+15.18%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
(+14%)
Cap. Flow
+$16.6M
Cap. Flow
% of AUM
10.01%
Top 10 Holdings %
Top 10 Hldgs %
57.53%
Holding
45
New
15
Increased
6
Reduced
8
Closed
16
Top Buys
| 1 |
Medtronic
MDT
|
$10.5M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$10.2M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$9.01M |
| 4 |
Cytokinetics
CYTK
|
$8.8M |
| 5 |
Quanterix
QTRX
|
$8.06M |
Top Sells
| 1 |
Centene
CNC
|
$12M |
| 2 |
Sotera Health
SHC
|
$10.2M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$9.36M |
| 4 |
Adaptive Biotechnologies
ADPT
|
$6.87M |
| 5 |
ESSA Pharma
EPIX
|
$6.07M |
Sector Composition
| 1 | Healthcare | 99.56% |
| 2 | Financials | 0.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alkermes
ALKS
$4.78B
| $11.5M | 6.92% | 373,382 +68,137 | +22% | +$2.1M |
|
|
2
Medtronic
MDT
$119B
| $10.5M | 6.31% | +83,737 | New | +$10.5M |
|
3
Insulet
PODD
$23.9B
| $10.4M | 6.28% | 36,732 +7,789 | +27% | +$2.21M |
|
4
Hologic
HOLX
$14.9B
| $10.3M | 6.16% | 138,884 +92,700 | +201% | +$6.84M |
|
|
SAGE
5
DELISTED
Sage Therapeutics
SAGE
| $10.2M | 6.1% | +229,117 | New | +$10.2M |
|
|
DICE
6
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $9.01M | 5.42% | +275,165 | New | +$9.01M |
|
|
ARNA
7
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.93M | 5.37% | 150,001 +7,755 | +5% | +$462K |
|
|
8
Cytokinetics
CYTK
$4.23B
| $8.8M | 5.29% | +246,336 | New | +$8.8M |
|
|
9
Quanterix
QTRX
$211M
| $8.06M | 4.85% | +161,933 | New | +$8.06M |
|
10
PTC Therapeutics
PTCT
$3.92B
| $8.04M | 4.83% | +215,985 | New | +$8.04M |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.43M | 4.47% | 41,991 -15,988 | -28% | -$2.83M |
|
12
AstraZeneca
AZN
$248B
| $6.98M | 4.2% | 116,242 -59,768 | -34% | -$3.59M |
|
|
BLU
13
DELISTED
BELLUS Health Inc.
BLU
| $6.59M | 3.96% | +1,072,698 | New | +$6.59M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $6.25M | 3.75% | 653,976 +354,692 | +119% | +$3.39M |
|
|
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.77M | 3.47% | +355,396 | New | +$5.77M |
|
16
Kymera Therapeutics
KYMR
$2.95B
| $5.23M | 3.15% | 89,071 -34,292 | -28% | -$2.01M |
|
17
Baxter International
BAX
$12.7B
| $4.95M | 2.98% | +61,570 | New | +$4.95M |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.65M | 2.79% | 474,368 +74,592 | +19% | +$731K |
|
19
Aclaris Therapeutics
ACRS
$209M
| $4.35M | 2.62% | 241,701 -74,133 | -23% | -$1.33M |
|
20
Kura Oncology
KURA
$686M
| $3.64M | 2.19% | +194,309 | New | +$3.64M |
|
21
Avidity Biosciences
RNA
$5.99B
| $3.11M | 1.87% | +126,116 | New | +$3.11M |
|
22
PMV Pharmaceuticals
PMVP
$74.2M
| $3.01M | 1.81% | 100,882 -894 | -0.9% | -$26.6K |
|
|
HZNP
23
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.73M | 1.64% | +24,949 | New | +$2.73M |
|
24
iTeos Therapeutics
ITOS
$449M
| $1.55M | 0.93% | 57,286 -3,962 | -6% | -$107K |
|
25
Avalo Therapeutics
AVTX
$122M
| $1.17M | 0.7% | +534,621 | New | +$1.17M |
|